Revenues Revenues (Tables)

12 Months Ended

Dec. 31, 2018

Revenues [Abstract]

Disaggregation of Revenue [Table Text Block]

Disaggregation of Revenues

The following table presents revenue disaggregated by timing of recognition and major product lines for the year ended December 31, 2018.

	Topic 606 Revenue						Topic 815(1)		Total
	Point in Time		Over Time		Total		Revenue		Revenues
	(In millions)
Origination
Merchandising and Handling	$	2,182	$	237	$	2,419	$	22,397	$	24,816
Transportation	—		244		244		—		244
Total Origination	2,182		481		2,663		22,397		25,060
Oilseeds
Crushing and Origination	664		—		664		16,279		16,943
Refining, Packaging, Biodiesel, and Other	1,792		—		1,792		6,096		7,888
Total Oilseeds	2,456		—		2,456		22,375		24,831
Carbohydrate Solutions
Starches and Sweeteners	4,901		—		4,901		1,795		6,696
Bioproducts	3,583		—		3,583		—		3,583
Total Carbohydrate Solutions	8,484		—		8,484		1,795		10,279
Nutrition
Wild Flavors and Specialty Ingredients	2,571		—		2,571		—		2,571
Animal Nutrition	1,219		—		1,219		—		1,219
Total Nutrition	3,790		—		3,790		—		3,790
Other	381		—		381		—		381
Total Revenues	$	17,293	$	481	$	17,774	$	46,567	$	64,341

⁽¹⁾ Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts that are accounted for as derivatives and are outside the scope of Topic 606.

Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]

Impacts on Financial Statements

The following tables summarize the impacts of Topic 606 adoption on the various lines of the Company’s consolidated financial statements.

Consolidated Balance Sheets (excerpt)

	January 1, 2018		December 31, 2018
	After Adoption		As		Under		Effect of
	of Topic 606		Reported		Topic 605		Change
	(In millions)
Assets
Trade receivables	$	2,343	$	2,233	$	1,989	$	244
Inventories	8,770		8,813		9,049		(236		)
Other current assets	3,175		3,033		3,056		(23		)
Total Current Assets	19,918		20,588		20,603		(15		)
Total Assets	$	39,956	$	40,833	$	40,848	$	(15	)
Liabilities, Temporary Equity, and Shareholders’ Equity
Accrued expenses and other payables	$	2,826	$	2,913	$	2,926	$	(13	)
Total Current Liabilities	12,563		11,776		11,789		(13		)
Reinvested earnings	17,552		18,527		18,529		(2		)
Total Shareholders’ Equity	18,322		18,996		18,998		(2		)
Total Liabilities, Temporary Equity, and Shareholders’ Equity	$	39,956	$	40,833	$	40,848	$	(15	)

Consolidated Statements of Earnings (excerpt)

	Twelve Months Ended
	December 31, 2018
	As		Under		Effect of
	Reported		Topic 605		Change
	(In millions)
Revenues	$	64,341	$	64,502	$	(161	)
Cost of products sold	60,160		60,319		(159		)
Gross profit	4,181		4,183		(2		)
Earnings before income taxes	2,060		2,062		(2		)
Income taxes	245		245		—
Net earnings including noncontrolling interests	1,815		1,817		(2		)
Net earnings attributable to controlling interests	1,810		1,812		(2		)